CSGALNACT2-DT
gene geneOn this page
Summary
CSGALNACT2-DT (CSGALNACT2 divergent transcript, HGNC:55174) is a long non-coding RNA gene on chromosome 10q11.21.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:55174 |
| Approved symbol | CSGALNACT2-DT |
| Name | CSGALNACT2 divergent transcript |
| Location | 10q11.21 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000273008 |
| Ensembl biotype | lncRNA |
| Entrez | 118568825 |
| RNAcentral | URS00026A2369 — lncRNA, 1570 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 lncRNA
ENST00000609407, ENST00000796738
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000609407 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003705074 | 43136824 | 43138334 |
Expression profiles
Bgee: expression breadth ubiquitous, 129 present calls, max score 82.99.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 1.9690 / max 34.2600, expressed in 1005 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 109156 | 1.4613 | 819 |
| 109155 | 0.5077 | 217 |
Top tissues by expression
129 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 82.99 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 75.45 | gold quality |
| bone marrow cell | CL:0002092 | 64.96 | silver quality |
| right uterine tube | UBERON:0001302 | 64.07 | gold quality |
| cortical plate | UBERON:0005343 | 64.02 | gold quality |
| pituitary gland | UBERON:0000007 | 63.71 | gold quality |
| granulocyte | CL:0000094 | 63.61 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 63.51 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 63.25 | gold quality |
| cerebellar cortex | UBERON:0002129 | 63.21 | gold quality |
| cerebellum | UBERON:0002037 | 63.10 | gold quality |
| ascending aorta | UBERON:0001496 | 62.90 | gold quality |
| thoracic aorta | UBERON:0001515 | 62.90 | gold quality |
| myometrium | UBERON:0001296 | 62.89 | gold quality |
| body of uterus | UBERON:0009853 | 62.78 | gold quality |
| bone marrow | UBERON:0002371 | 62.64 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 62.61 | gold quality |
| adenohypophysis | UBERON:0002196 | 62.25 | gold quality |
| popliteal artery | UBERON:0002250 | 62.25 | gold quality |
| tibial artery | UBERON:0007610 | 62.23 | gold quality |
| left coronary artery | UBERON:0001626 | 61.81 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 61.33 | gold quality |
| lower esophagus | UBERON:0013473 | 61.24 | gold quality |
| ganglionic eminence | UBERON:0004023 | 60.69 | gold quality |
| endocervix | UBERON:0000458 | 60.49 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 60.09 | gold quality |
| ventricular zone | UBERON:0003053 | 60.07 | gold quality |
| right coronary artery | UBERON:0001625 | 60.04 | gold quality |
| right lung | UBERON:0002167 | 59.85 | gold quality |
| stromal cell of endometrium | CL:0002255 | 59.79 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.25 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.